Could a low-dose drug help relieve chronic fatigue and Long-COVID?
Symptom relief
ENROLLING_BY_INVITATION
This study looks at whether low-dose rapamycin can reduce symptoms and improve quality of life in people with ME/CFS or Long-COVID. About 150 participants will take the drug as prescribed by their doctor and complete surveys and blood tests over time. The goal is to see if the dr…
Sponsor: Simmaron Research Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC